Profilo
Mr. Adam Townsend is a President, Chief Executive Officer & Director at Merida Biosciences, Inc. He is on the Board of Directors at Merida Biosciences, Inc. Mr. Townsend was previously employed as a Chief Operating Officer by Apellis Pharmaceuticals, Inc., a Senior Vice President-Corporate Development by Biogen, Inc., and a General Manager-UK, Ireland & Nordic Region by EUSA Pharma, Inc. He received his undergraduate degree from Royal Holloway University of London.
Posizioni attive di Adam Townsend
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Adam Townsend
| Società | Posizione | Fine |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Direttore operativo | 21/02/2025 |
| BIOGEN INC. | Corporate Officer/Principal | 01/10/2018 |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Corporate Officer/Principal | 01/03/2010 |
Formazione di Adam Townsend
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Royal Holloway University of London
Royal Holloway University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















